Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0257-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0256-2022
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0469-03 D-0811-2021
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0469-56 D-0810-2021
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0468-56 D-0809-2021
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 00069-0471-03 D-0808-2021
Class II · Moderate risk

Combipatch

Failed Stability Specifications; out of specification for shear.

Ongoing Stability / shelf life Noven Pharmaceuticals Inc NDC 68968-0525-2 D-0725-2021
Class II · Moderate risk

Combipatch

Failed Stability Specifications; out of specification for shear.

Ongoing Stability / shelf life Noven Pharmaceuticals Inc NDC 68968-0514-2 D-0724-2021
Class II · Moderate risk

Miss Slim

Marketed without ANDA/NDA approval

Ongoing Other His Enterprise INC D-0770-2021

Recalls by year